tae-life-sciences-logo-color_thumb

TAE Life Sciences and Bozlu Holding Announce Exclusive Distribution Agreement to Expand TAE Life Sciences’ Next-Gen Targeted Cancer Treatment Platform Across Turkiye, Eastern Europe, and Central Asia

TAE Life Sciences has announced a distribution agreement with alphaXRT, a premier provider of advanced radiation therapy technologies. Under this partnership, alphaXRT will distribute TAE Life Sciences’ Alphabeam™ BNCT system and novel boron drugs, while also providing associated services across Australia and New Zealand.